Pharmaceuticals, Biotechnology and Life Sciences
TORONTO, Dec. 31, 2024 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence…
Hamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) — Further proof of great versatility of Altamira’s platform for extrahepatic RNA deliveryCircular…
MIAMI, FL, Dec. 31, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuationsEnrollment to be extended…
DALLAS, Dec. 31, 2024 (GLOBE NEWSWIRE) — Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven…
AGOURA HILLS, Calif., Dec. 31, 2024 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We” or “Our”),…
CLEVELAND, , Dec. 31, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards…
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of…
GUANGZHOU, China, Dec. 31, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a…
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company…